Industry-Leading Provider of microCT Systems and Solutions

SCANCO Medical has been a pioneer in the field of high-resolution computed tomography for more than three decades. Starting with the first installation in Switzerland in 1988 we now have systems for medical and industrial applications operating on six continents.

We offer a wide range of microCT scanners for specimen and preclinical as well as clinical use. These systems are supplied with high-end computing equipment and sophisticated analysis and visualization software to provide the most comprehensive and industry-leading imaging solutions.

SCANCO Medical also offers scanning, analysis and consulting services for a wide range of applications.

SCANCO Medical scanners are used on many of the most prominent universities and research institutions world wide.

07.10.2023

Updated Publication List for XtremeCT

see Publication List page

more...

18.07.2023

User Meeting Appenzell 2023 November 15-18, 2023

Updated information (preliminary program, travel/accommodation etc.)

It has been five years since we last met as a group and we are therefore happy to invite you all again to our upcoming User Meeting.

The 2023 SCANCO User Meeting will be held again in Appenzell, Switzerland. Many of you certainly remember this place and will hopefully be happy to return after the 2008, 2013 and 2018 editions.

Find information here (see also for registrations)


more...

11.07.2023

SCANCO Medical AG receives EU Medical Device Regulation Quality Management Certificate

SCANCO Medical is pleased to announce receipt of the EU Medical Device Regulation (MDR) certification by its Notified Body, TÜV Süd Product Service GmbH, Germany.

This signifies that the Quality Management System and the corresponding product, XtremeCT II, meet the requirements of the new MDR by the European Union.
 
The XtremeCT II is designed to measure the bone density and to quantify the three-dimensional microarchitecture of the bone at the distal radius and tibia at an even higher precision and speed than its predecessor, the XtremeCT.
 
XtremeCT II is currently approved as a medical device in Europe (under MDD and MDR), Canada and Japan.

The new Medical Device Regulation was implemented by the European Union in 2017 and became fully active on May 26, 2021 with a transition period until December 2028. It will replace the current Medical Device Directive.

more...

15.06.2023

XtremeCT User Meeting 2023

The 9th XtremeCT user meeting will be held Tuesday 17th October 2023 in Vancouver
If you did not receive an invitation email and would like to attend, please contact events@scanco.ch

more...

Life Sciences

Life Sciences

Clinical

Clinical

Materials

Materials